Prognostic molecular signature of sarcomas, and uses thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9708666
SERIAL NO

13265764

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Described herein are methods and compositions that can be used for diagnosis and treatment of soft tissue sarcoma cancer phenotypes and soft tissue sarcoma cancer-associated diseases. Also described herein are methods that can be used to identify modulators of soft tissue sarcoma cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
INSTITUT CURIE75005 PARIS
UNIVERSITE BORDEAUX SEGALEN146 RUE LEO SAIGNAT BORDEAUX CEDEX F-33076
INSTITUT BERGONIE229 COURS DE I'ARGONNE BORDEAUX CEDEX F-33076

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Aurias, Alain Bures-sur-Yvette, FR 3 11
Chibon, Frédéric Isle-Saint-Georges, FR 2 1
Coindre, Jean-Michel Bordeaux, FR 2 1

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jan 18, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 18, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00